Business
Why the ResApp (ASX:RAP) share price is climbing higher
The ResApp Health Ltd (ASX: RAP) share price is climbing higher today. This comes after the company provided an update of its prescription-only software application with the United States Food and Drug Administration (FDA).
At the time of writing, shares in the digital health company are trading 1.4% higher at 6.8 cents.
What did ResApp announce?
In today’s release, ResApp advised it has sent a pre-submission package to the FDA for clearance on its smartphone-based medical software application. The company also requested a meeting with the FDA to discuss how to obtain regulatory approval and any other requirements.
ResApp’s latest software application uses machine-learning algorithms to detect cough sounds recorded by a…
-
Noosa News21 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business23 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Noosa News21 hours agoE-biker charged with riding dangerously, assaulting cop
-
General20 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands